Abstract
Nanotechnology has potential to revolutionize diagnosis and therapy of diseases in the central nervous system
through nanotheranostics. This simply states that a nanocarrier can be designed in an ‘all-in-one’ approach to facilitate
both the functions of a diagnostic and a therapeutic drug. There are many challenges that must be overcome for
these nanocarriers to become a successful design, but if resolved nanocarriers could pave the way for personalised
medicine. This review highlights several new ideas behind nanotheranostics design and testing with a particular focus
on cancerous tumours in the brain.
| Original language | English |
|---|---|
| Article number | 0006 |
| Journal | Journal of Nanomedicine and Nanotechnology |
| Volume | S4 |
| DOIs | |
| Publication status | Published - 2012 |
Access to Document
- Pascu_JNMNT_2012.pdf
© 2012 Chapman M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.